Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
Paxlovid soon will not be free for Americans
Dec 07, 2022
At this point, about 6 million Americans have taken free Paxlovid doses.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Israel will give fourth COVID-19 shot to people older than 60, health workers
Jan 03, 2022
About 60% of Israel’s 9.4 million people are fully vaccinated with either a recent second dose or booster dose.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.